| Literature DB >> 32825198 |
Bo-Rong Peng1,2,3, Kuei-Hung Lai4,5, Yu-Chia Chang5, You-Ying Chen3,6, Jui-Hsin Su3,7, Yusheng M Huang8, Po-Jen Chen9, Steve Sheng-Fa Yu2,10, Chang-Yih Duh1,6, Ping-Jyun Sung3,6,7,11,12.
Abstract
Scalarane-type sesterterpenoids are known for their therapeutic potential in cancer treatments. However, the anti-inflammatory properties of this class of metabolites remain elusive. Our current work aimed to investigate the anti-inflammatory scalaranes from marine sponge Lendenfeldia sp., resulting in the isolation of six new 24-homoscalaranes, lendenfeldaranes E-J (1-6). The structures of the new metabolites were determined by extensive spectroscopic analyses, and the absolute configuration of 1 was established by electronic circular dichroism (ECD) calculations. Compounds 2 and 3 were discovered to individually reduce the generation of superoxide anions, and compound 1 displayed an inhibitor effect on the release of elastase. These three compounds were proven to be the first anti-neutrophilic scalaranes.Entities:
Keywords: 24-homoscalarane; Lendenfeldia; NADPH oxidase; anti-neutrophilic inflammation; elastase release; lendenfeldarane; sesterterpenoid; superoxide anion
Mesh:
Substances:
Year: 2020 PMID: 32825198 PMCID: PMC7551342 DOI: 10.3390/md18090434
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of lendenfeldaranes E–J (1–6) and felixin E (7) and a picture of Lendenfeldia sp.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data for 24-homoscalaranes 1 and 2.
| 1 | 2 | |||
|---|---|---|---|---|
| C/H | δH ( | δC Mult. | δH ( | δC Mult. |
| 1 | 1.59 m; 0.80 m | 39.4, CH2 | 1.99 m; 0.77 m | 34.3, CH2 |
| 2 | 1.43 m; 1.58 m | 18.1, CH2 | 1.46 m; 1.58 m | 17.9, CH2 |
| 3 | 1.10 m; 1.36 m | 41.8, CH2 | 1.14 m; 1.43 m | 41.4, CH2 |
| 4 | 33.3, C | 33.0, C | ||
| 5 | 0.81 m | 56.6, CH | 0.97 m | 56.9, CH |
| 6 | 1.43 m | 18.4, CH2 | 1.46 m | 18.1, CH2 |
| 7 | 0.92 ddd (12.8, 12.8, 4.0) | 41.9, CH2 | 0.98 m; 1.90 m | 42.2, CH2 |
| 1.82 ddd (12.8, 2.8, 2.8) | ||||
| 8 | 37.8, C | 37.7, C | ||
| 9 | 1.15 m | 61.3, CH | 1.26 m | 61.1, CH |
| 10 | 38.1, C | 41.2, C | ||
| 11 | 2.66 dd (14.4, 13.6) | 35.1, CH2 | 2.99 dd (14.8, 13.6) | 37.9, CH2 |
| 2.24 dd (13.6, 2.0) | 2.43 dd (13.6, 2.4) | |||
| 12 | 215.3, C | 214.8, C | ||
| 13 | 51.8, C | 51.9, C | ||
| 14 | 1.13 m | 59.6, CH | 1.13 m | 59.7, CH |
| 15 | 1.52 m; 1.90 m | 30.8, CH2 | 1.56 m; 1.92 m | 31.0, CH2 |
| 16 | 3.43 ddd (10.4, 10.4, 4.4) | 74.8, CH | 3.43 ddd (10.0, 10.0, 4.4) | 74.6, CH |
| 17 | 1.89 m | 49.6, CH | 1.91 m | 49.5, CH |
| 18 | 1.62 m | 53.0, CH | 1.60 m | 52.8, CH |
| 19 | 0.82 s | 21.3, CH3 | 0.84 s | 21.8, CH3 |
| 20 | 0.85 s | 33.2, CH3 | 0.87 s | 33.7, CH3 |
| 21 | 1.07 s | 17.1, CH3 | 1.15 s | 16.5, CH3 |
| 22 | 0.86 s | 15.7, CH3 | 4.19 dd (12.4, 1.6); 4.65 d (12.4) | 64.6, CH2 |
| 23 | 1.36 s | 15.3, CH3 | 1.37 s | 15.4, CH3 |
| 24 | 3.84 qd (6.0, 2.4) | 78.7, CH | 3.83 qd (6.0, 2.0) | 78.8, CH |
| 25 | 5.35 d (4.0) | 104.8, CH | 5.33 d (4.4) | 104.7, CH |
| 26 | 1.40 d (6.0) | 23.5, CH3 | 1.40 d (6.0) | 23.5, CH3 |
| 22-OAc | 170.7, C | |||
| 2.04 s | 21.1, CH3 | |||
| 25-OMe | 3.30 s | 54.4, CH3 | 3.28 s | 54.4, CH3 |
Figure 2The COSY () and HMBC () of 1–6.
Figure 3The selected NOESY correlations () of 1 and 2.
Figure 4Calculated and experimental electronic circular dichroism (ECD) spectra of 1.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data for 24-homoscalaranes 3 and 4.
| 3 | 4 | |||
|---|---|---|---|---|
| C/H | δH ( | δC Mult. | δH ( | δC Mult. |
| 1 | 2.04 m; 0.82 m | 34.5, CH2 | 2.03 m; 0.84 m | 34.6, CH2 |
| 2 | 1.45 m; 1.56 m | 18.4, CH2 | 1.45 m; 1.56 m | 18.4, CH2 |
| 3 | 1.18 m; 1.43 m | 41.5, CH2 | 1.17 br d (3.6); 1.42 m | 41.5, CH2 |
| 4 | 32.9, C | 33.0, C | ||
| 5 | 1.10 m | 56.6, CH | 1.09 m | 56.6, CH |
| 6 | 1.56 m | 18.1, CH2 | 1.56 m | 18.1, CH2 |
| 7 | 1.09 m; 1.78 ddd (12.8, 3.2, 3.2) | 42.0, CH2 | 1.08 m; 1.79 ddd (12.4, 3.2, 3.2) | 42.1, CH2 |
| 8 | 37.6, C | 37.6, C | ||
| 9 | 1.57 m | 52.0, CH | 1.58 m | 52.1, CH |
| 10 | 40.1, C | 40.2, C | ||
| 11 | 1.89 m; 1.29 m | 31.3, CH2 | 1.90 m; 1.29 m | 31.3, CH2 |
| 12 | 3.57 br s | 72.0, CH | 3.67 ddd (3.2, 3.2, 3.2) | 72.1, CH |
| 13 | 39.0, C | 39.0, C | ||
| 14 | 1.38 m | 52.2, CH | 1.40 m | 52.2, CH |
| 15 | 1.86–1.98 m | 25.9 CH2 | 1.91 m, 2.00 m | 26.1 CH2 |
| 16 | 3.55 ddd (10.0, 10.0, 4.8) | 72.9, CH | 3.58 ddd (10.0, 10.0, 4.8) | 73.0, CH |
| 17 | 1.57 m | 51.7, CH | 1.58 m | 52.1, CH |
| 18 | 1.92 m | 55.8, CH | 1.94 m | 56.7, CH |
| 19 | 0.82 s | 21.8, CH3 | 0.82 s | 21.8, CH3 |
| 20 | 0.86 s | 33.7, CH3 | 0.87 s | 33.7, CH3 |
| 21 | 0.90 s | 16.1, CH3 | 0.91 s | 16.1, CH3 |
| 22 | 4.17 d (11.6); 4.56 d (11.6) | 65.0, CH2 | 4.18 dd (12.0, 0.8); 4.57 d (12.0) | 65.0, CH2 |
| 23 | 0.93 s | 16.3, CH3 | 0.94 s | 16.2, CH3 |
| 24 | 3.98 qd (6.0, 3.2) | 79.5, CH | 4.09 qd (6.0, 3.2) | 79.7, CH |
| 25 | 4.85 d (6.4) | 103.9, CH | 5.35 dd (6.8, 3.2) | 96.5, CH |
| 26 | 1.37 d (6.0) | 20.3, CH3 | 1.36 d (6.0) | 20.5, CH3 |
| 22-OAc | 171.0, C | 171.0, C | ||
| 2.05 s | 21.2, CH3 | 2.06 s | 21.2, CH3 | |
| 25-OMe | 3.45 s | 56.6, CH3 | ||
Figure 5The selected NOESY correlations () of 3 and 4.
1H and 13C NMR data for 24-homoscalaranes 5 and 6.
| 5 | 6 | |||
|---|---|---|---|---|
| C/H | δH ( | δC Mult. b | δH ( | δC Mult. d |
| 1 | 1.99 m; 0.80 m | 34.4, CH2 | 2.10 m; 0.51 ddd (12.6, 12.6, 3.6) | 34.3, CH2 |
| 2 | 1.49 m; 1.64 m | 18.0, CH2 | 1.43 m; 1.56 m | 18.1, CH2 |
| 3 | 1.15 m; 1.45 m | 41.4, CH2 | 1.13 m; 1.44 m | 41.7, CH2 |
| 4 | 33.0, C | 33.0, C | ||
| 5 | 0.97 m | 57.0, CH | 0.98 dd (12.6, 2.4) | 57.0, CH |
| 6 | 1.50 m; 1.60 m | 18.1, CH2 | 1.42 m; 1.57 m | 17.9, CH2 |
| 7 | 0.99 m; 1.87 m | 41.9, CH2 | 1.12 m, 1.90 m | 42.0, CH2 |
| 8 | 38.5, C | 37.0, C | ||
| 9 | 1.28 br d (14.0) | 63.3, CH | 1.31 dd (7.2, 7.2) | 53.5, CH |
| 10 | 41.6, C | 41.8, C | ||
| 11 | 3.15 dd (14.0, 12.4); 2.51 dd (12.4, 2.4) | 37.6, CH2 | 1.87–1.95 m | 27.9, CH2 |
| 12 | 211.9, C | 5.51 t (3.0) | 73.8, CH | |
| 13 | 50.0, C | 39.0, C | ||
| 14 | 0.95 m | 59.3, CH | 1.79 dd (12.6, 2.4) | 46.2, CH |
| 15 | 1.50 m; 1.97 m | 31.1, CH2 | 2.21 m | 23.9 CH2 |
| 16 | 3.61 ddd (9.6, 9.6, 4.4) | 72.0, CH | 4.46 dd (5.4, 5.4) | 61.7, CH |
| 17 | 1.92 m | 51.4, CH | 161.3, C | |
| 18 | 2.58 d (14.4) | 49.7, CH | 135.7, C | |
| 19 | 0.84 s | 21.8, CH3 | 0.77 s | 21.8, CH3 |
| 20 | 0.87 s | 33.7, CH3 | 0.87 s | 33.8, CH3 |
| 21 | 1.18 s | 16.6, CH3 | 1.10 s | 16.3, CH3 |
| 22 | 4.17 dd (11.6, 1.6); 4.67 d (11.6) | 64.6, CH2 | 3.88 dd (11.4, 4.8); 4.04 d (11.4) | 62.8, CH2 |
| 23 | 1.38 s | 14.7, CH3 | 1.16 s | 19.4, CH3 |
| 24 | 4.30 qd (6.0, 2.4) | 79.5, CH | 5.07 q (6.6) | 76.5, CH |
| 25 | 172.3, C | 170.5, C | ||
| 26 | 1.53 d (6.0) | 20.1, CH3 | 1.41 d (6.6) | 18.3, CH3 |
| 12-OAc | 169.8, C | |||
| 1.98 s | 21.2, CH3 | |||
| 22-OAc | 170.7, C | |||
| 2.06 s | 21.1, CH3 | |||
a 400 MHz, CDCl3. b 100 MHz, CDCl3. c 600 MHz, CDCl3. d 150 MHz, CDCl3.
Figure 6The selected NOESY correlations () of 5 and 6.
Inhibitory effects of 24-homoscalaranes 1–6 on superoxide anion generation and elastase release by human neutrophils in response to fMLF.
| Compound | Superoxide Anions | Elastase Release | ||||
|---|---|---|---|---|---|---|
| IC50 (μM) a | Inh (Enh) b % | IC50 (μM) a | Inh % | |||
| 1 | (11.35 ± 3.65) | * | 1.74 ± 0.08 | 82.80 ± 3.91 | *** | |
| 2 | 6.17 ± 0.16 | 70.68 ± 3.86 | *** | 26.15 ± 3.40 | ** | |
| 3 | 6.81 ± 0.52 | 62.92 ± 2.58 | *** | 25.19 ± 4.01 | ** | |
| 4 | 7.13 ± 3.69 | 2.97 ± 1.63 | ||||
| 5 | 9.97 ± 4.38 | 6.81 ± 2.46 | ||||
| 6 | 4.52 ± 2.91 | 1.16 ± 0.89 | ||||
Percentage of inhibition (Inh %) at 10 μM. Results are presented as mean ± S.E.M. (n = 3~5). * p < 0.05, ** p < 0.01, *** p < 0.001 compared with the control (DMSO). a Concentration necessary for 50 % inhibition (IC50). b Inh = inhibition, Enh = Enhancement.